Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin

被引：0
|
作者：
Jacqueline T Jonker
Rutger W van der Meer
Luuk J Rijzewijk
Lisa M Menting
Michaela Diamant
Johannes A Romijn
Johannes WA Smit
Albert de Roos
Hildo J Lamb
机构：
[1] Leiden University Medical Centre,Diabetes Centre
[2] VU University Medical Centre,undefined
来源：
Journal of Cardiovascular Magnetic Resonance | / 11卷 / Suppl 1期
关键词：
Metformin; Glycemic Control; Pioglitazone; Increase Body Weight; Pioglitazone Group;
D O I：
10.1186/1532-429X-11-S1-P113
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of pioglitazone on body fat and fat distribution in patients with Type 2 diabetes mellitus
    Storey, AM
    Perry, CJ
    Petrie, JR
    Priest, M
    Lean, MEJ
    [J]. DIABETOLOGIA, 2002, 45 : A235 - A235
  • [2] Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus
    Jonker, J. T.
    Lamb, H. J.
    van der Meer, R. W.
    Rijzewijk, L. J.
    Menting, L. J.
    Diamant, M.
    Bax, J. J.
    de Roos, A.
    Romijn, J. A.
    Smit, J. W. A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 456 - 460
  • [3] A Differential Effect of Pioglitazone Versus Metformin on Fat Depots in Patients with Type 2 Diabetes Mellitus
    Jonker, Jacqueline T.
    Van der Meer, Rutger W.
    Rijzewijk, Luuk J.
    Menting, Lisa J.
    Diamant, Michaela
    De Roos, Albert
    Lamb, Hildo J.
    Smit, Johannes W. A.
    Romijn, Johannes A.
    [J]. DIABETES, 2009, 58 : A172 - A172
  • [4] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    [J]. DIABETOLOGIA, 2002, 45 : A251 - A252
  • [5] Effects of Pioglitazone on Intramyocellular Fat Metabolism in Patients with Type 2 Diabetes Mellitus
    Bajaj, Mandeep
    Baig, Rais
    Suraamornkul, Swangjit
    Hardies, Lou Jean
    Coletta, Dawn K.
    Cline, Gary W.
    Monroy, Adriana
    Koul, Shailja
    Sriwijitkamol, Apiradee
    Musi, Nicolas
    Shulman, Gerald I.
    DeFronzo, Ralph A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (04): : 1916 - 1923
  • [6] Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus
    Forst, Thomas
    Weber, Matthias M.
    Loebig, Mirjam
    Lehmann, Ute
    Mueller, Juergen
    Hohberg, Cloth
    Friedrich, Christiane
    Fuchs, Winfried
    Pfuetzner, Andreas
    [J]. CLINICAL SCIENCE, 2010, 119 (7-8) : 345 - 351
  • [7] Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
    Gupta, Alok K.
    Bray, George A.
    Greenway, Frank L.
    Martin, Corby K.
    Johnson, William D.
    Smith, Steven R.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2010, 24 (05) : 289 - 296
  • [8] Combination therapy for patients with uncontrolled type 2 diabetes mellitus: adding empagliflozin to pioglitazone or pioglitazone plus metformin
    Blevins, Thomas
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 789 - 793
  • [9] Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
    Holland, Daniel Q.
    Neumiller, Joshua J.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 277 - 288
  • [10] Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (08) : 1773 - 1788
12345